Ziprasidone mesylate and Leukopenia - a phase IV clinical study of FDA data

Summary:

Leukopenia is reported as a side effect among people who take Ziprasidone mesylate (ziprasidone mesylate), especially for people who are male, 40-49 old, also take Amisulpride, and have Schizophrenia.

The phase IV clinical study analyzes which people have Leukopenia when taking Ziprasidone mesylate. It is created by eHealthMe based on reports of 165 people who have side effects when taking Ziprasidone mesylate from the FDA, and is updated regularly.

What is Ziprasidone mesylate?

Ziprasidone mesylate has active ingredients of ziprasidone mesylate. eHealthMe is studying from 183 Ziprasidone mesylate users. Check the latest studies of Ziprasidone mesylate.

What is Leukopenia?

Leukopenia (less number of white blood cells in blood) is found to be associated with 1,683 drugs and 2,290 conditions by eHealthMe. Check the latest studies of Leukopenia.

On Jul, 27, 2026

165 people reported to have side effects when taking Ziprasidone mesylate.
Among them, 50 people (30.3%) have Leukopenia.

Could Ziprasidone mesylate cause Leukopenia?

Among these 50 people:

What is the gender of people who have Leukopenia when taking Ziprasidone mesylate? *

female: 0.0 %
male: 100 %

What is the age of people who have Leukopenia when taking Ziprasidone mesylate? *

What are other drugs people take besides Ziprasidone mesylate? *

What are other side effects people have besides Leukopenia? *

Weight Loss: 50 people, 100.00%
Suicide Attempt: 50 people, 100.00%
Akathisia (a movement disorder characterized by a feeling of inner restlessness): 50 people, 100.00%
Obsessive-Compulsive Disorder (an anxiety disorder characterized by intrusive thoughts that produce uneasiness, apprehension, fear, or worry;): 50 people, 100.00%
Appetite - Increased (increased appetite is when you want to eat much more often or in larger quantities than your body requires): 50 people, 100.00%
Disinhibition (loss of inhibition): 50 people, 100.00%
High Blood Pressure: 50 people, 100.00%
Euphoric Mood (excessively happy but may become angry or irritable): 50 people, 100.00%
Weight Increased: 50 people, 100.00%
Dyslipidaemia (abnormal amount of lipids): 50 people, 100.00%

What are the existing conditions these people have? *

Schizophrenia (a mental disorder characterized by a breakdown of thought processes): 50 people, 100.00%
Psychotic Disorder: 39 people, 78.00%
Affective Disorder (mental disorder): 37 people, 74.00%
Depression: 28 people, 56.00%

* Approximation only. Some reports may have incomplete information.

Do you take Ziprasidone mesylate and have Leukopenia?

- Check whether Leukopenia is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Ziprasidone mesylate:

Ziprasidone mesylate (183 reports)

Leukopenia treatments and more:

Leukopenia (58,665 reports)

Browse all side effects of Ziprasidone mesylate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Leukopenia:

Leukopenia (1,683 drugs)

Browse all the conditions that are associated with Leukopenia:

Leukopenia (2,290 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on ziprasidone mesylate (the active ingredients of Ziprasidone mesylate) and Ziprasidone mesylate (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.